Clinical Trial

Rate of Bone Union After Surgery With Stand-alone Fibergraft

Study acronym: Fibergraft
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 30, 2025 (before its estimated May 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
Some people have back problems caused by degenerative conditions or instability of the spine (eg. Spondylolisthesis). These problems can lead to pain, nerve issues, or difficulties in walking. A common treatment is a type of back surgery called lumbar interbody fusion, which helps stabilize the spine. At the St. Maartenskliniek in the Netherlands, doctors have been using a special material called Fibergraft Bioactive Glass Putty for such surgeries since 2023. This material helps bones grow and heal, and it's placed inside the spine without needing extra bone from another part of the body. This study will look at how well this material works by evaluating how many patients' bones successfully healed after surgery using this material. It will also look at how patients feel and recover after the procedure
Trial Details
NCT Number NCT07199075
Lead Sponsor AO Innovation Translation Center
Conditions Spine Degeneration, Spine Disorder, Spine Pain, Spine Fusion, Spine Fusion for Degenerative Spine Disease, Nerve Root Compress;Lumbosac, Spondylolisthesis
Enrollment 80 participants
Start Date 2025-10-31
Primary Completion 2026-05-30 (estimated)
Study Completion 2026-05-30 (estimated)
Updated on ClinicalTrials.gov 2025-09-30